nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—hypertension—type 2 diabetes mellitus	0.716	1	CtDrD
Esmolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0995	1	CbGbCtD
Esmolol—Ibuprofen—THBD—type 2 diabetes mellitus	0.000637	0.169	CrCbGaD
Esmolol—Alprenolol—ADRB3—type 2 diabetes mellitus	0.00054	0.144	CrCbGaD
Esmolol—Pindolol—ADRB3—type 2 diabetes mellitus	0.000465	0.124	CrCbGaD
Esmolol—Ibuprofen—PLAT—type 2 diabetes mellitus	0.000437	0.116	CrCbGaD
Esmolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.000254	0.0674	CrCbGaD
Esmolol—Ibuprofen—BCL2—type 2 diabetes mellitus	0.000251	0.0667	CrCbGaD
Esmolol—Betaxolol—CYP1A2—type 2 diabetes mellitus	0.000205	0.0544	CrCbGaD
Esmolol—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000152	0.00108	CcSEcCtD
Esmolol—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000151	0.00108	CcSEcCtD
Esmolol—Chills—Irbesartan—type 2 diabetes mellitus	0.000151	0.00108	CcSEcCtD
Esmolol—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00015	0.00107	CcSEcCtD
Esmolol—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00015	0.00107	CcSEcCtD
Esmolol—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00015	0.00107	CcSEcCtD
Esmolol—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000149	0.00106	CcSEcCtD
Esmolol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000149	0.00106	CcSEcCtD
Esmolol—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000148	0.00106	CcSEcCtD
Esmolol—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000148	0.00106	CcSEcCtD
Esmolol—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000148	0.00106	CcSEcCtD
Esmolol—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000148	0.00106	CcSEcCtD
Esmolol—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000147	0.00105	CcSEcCtD
Esmolol—Flushing—Losartan—type 2 diabetes mellitus	0.000147	0.00105	CcSEcCtD
Esmolol—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000147	0.00105	CcSEcCtD
Esmolol—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000146	0.00104	CcSEcCtD
Esmolol—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000146	0.00104	CcSEcCtD
Esmolol—Erythema—Irbesartan—type 2 diabetes mellitus	0.000146	0.00104	CcSEcCtD
Esmolol—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000146	0.00104	CcSEcCtD
Esmolol—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000146	0.00104	CcSEcCtD
Esmolol—Convulsion—Orlistat—type 2 diabetes mellitus	0.000146	0.00104	CcSEcCtD
Esmolol—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000146	0.00104	CcSEcCtD
Esmolol—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000145	0.00104	CcSEcCtD
Esmolol—Chest pain—Valsartan—type 2 diabetes mellitus	0.000145	0.00103	CcSEcCtD
Esmolol—Dizziness—Glipizide—type 2 diabetes mellitus	0.000145	0.00103	CcSEcCtD
Esmolol—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000145	0.00103	CcSEcCtD
Esmolol—Anxiety—Valsartan—type 2 diabetes mellitus	0.000144	0.00103	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000144	0.00103	CcSEcCtD
Esmolol—Angiopathy—Losartan—type 2 diabetes mellitus	0.000144	0.00102	CcSEcCtD
Esmolol—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000143	0.00102	CcSEcCtD
Esmolol—Chest pain—Orlistat—type 2 diabetes mellitus	0.000143	0.00102	CcSEcCtD
Esmolol—Anxiety—Orlistat—type 2 diabetes mellitus	0.000143	0.00102	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000142	0.00101	CcSEcCtD
Esmolol—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000142	0.00101	CcSEcCtD
Esmolol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000141	0.00101	CcSEcCtD
Esmolol—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00014	0.000999	CcSEcCtD
Esmolol—Vomiting—Glipizide—type 2 diabetes mellitus	0.000139	0.000993	CcSEcCtD
Esmolol—Syncope—Metformin—type 2 diabetes mellitus	0.000139	0.000992	CcSEcCtD
Esmolol—Oedema—Valsartan—type 2 diabetes mellitus	0.000139	0.000991	CcSEcCtD
Esmolol—Ibuprofen—PPARG—type 2 diabetes mellitus	0.000139	0.037	CrCbGaD
Esmolol—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000139	0.00099	CcSEcCtD
Esmolol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000139	0.000989	CcSEcCtD
Esmolol—Erythema—Losartan—type 2 diabetes mellitus	0.000138	0.000982	CcSEcCtD
Esmolol—Oedema—Orlistat—type 2 diabetes mellitus	0.000137	0.00098	CcSEcCtD
Esmolol—Headache—Glipizide—type 2 diabetes mellitus	0.000137	0.000978	CcSEcCtD
Esmolol—Shock—Valsartan—type 2 diabetes mellitus	0.000137	0.000975	CcSEcCtD
Esmolol—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000136	0.000972	CcSEcCtD
Esmolol—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000136	0.000972	CcSEcCtD
Esmolol—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000136	0.000969	CcSEcCtD
Esmolol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000135	0.000964	CcSEcCtD
Esmolol—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000135	0.000963	CcSEcCtD
Esmolol—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000135	0.000962	CcSEcCtD
Esmolol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000135	0.000962	CcSEcCtD
Esmolol—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000135	0.000961	CcSEcCtD
Esmolol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000135	0.000961	CcSEcCtD
Esmolol—Agitation—Irbesartan—type 2 diabetes mellitus	0.000134	0.000959	CcSEcCtD
Esmolol—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000134	0.000959	CcSEcCtD
Esmolol—Chlorphenesin—CYP3A4—type 2 diabetes mellitus	0.000134	0.0357	CrCbGaD
Esmolol—Urticaria—Glyburide—type 2 diabetes mellitus	0.000134	0.000955	CcSEcCtD
Esmolol—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000134	0.000954	CcSEcCtD
Esmolol—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000133	0.000952	CcSEcCtD
Esmolol—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000133	0.00095	CcSEcCtD
Esmolol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000133	0.000947	CcSEcCtD
Esmolol—Anorexia—Valsartan—type 2 diabetes mellitus	0.000132	0.000945	CcSEcCtD
Esmolol—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000132	0.000943	CcSEcCtD
Esmolol—Chest pain—Metformin—type 2 diabetes mellitus	0.000132	0.000942	CcSEcCtD
Esmolol—Chlorphenesin—PTGS2—type 2 diabetes mellitus	0.000131	0.0349	CrCbGaD
Esmolol—Headache—Pioglitazone—type 2 diabetes mellitus	0.000131	0.000937	CcSEcCtD
Esmolol—Syncope—Irbesartan—type 2 diabetes mellitus	0.000131	0.000936	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000131	0.000935	CcSEcCtD
Esmolol—Bisoprolol—CYP3A4—type 2 diabetes mellitus	0.000131	0.0348	CrCbGaD
Esmolol—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000131	0.000933	CcSEcCtD
Esmolol—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000131	0.000932	CcSEcCtD
Esmolol—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00013	0.00093	CcSEcCtD
Esmolol—Nausea—Glipizide—type 2 diabetes mellitus	0.00013	0.000928	CcSEcCtD
Esmolol—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00013	0.000927	CcSEcCtD
Esmolol—Hypotension—Valsartan—type 2 diabetes mellitus	0.00013	0.000926	CcSEcCtD
Esmolol—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000924	CcSEcCtD
Esmolol—Pain—Gliclazide—type 2 diabetes mellitus	0.000129	0.000923	CcSEcCtD
Esmolol—Constipation—Gliclazide—type 2 diabetes mellitus	0.000129	0.000923	CcSEcCtD
Esmolol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000129	0.000918	CcSEcCtD
Esmolol—Headache—Glimepiride—type 2 diabetes mellitus	0.000128	0.000913	CcSEcCtD
Esmolol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000128	0.00091	CcSEcCtD
Esmolol—Agitation—Losartan—type 2 diabetes mellitus	0.000127	0.000903	CcSEcCtD
Esmolol—Oedema—Metformin—type 2 diabetes mellitus	0.000127	0.000903	CcSEcCtD
Esmolol—Flushing—Ramipril—type 2 diabetes mellitus	0.000126	0.000898	CcSEcCtD
Esmolol—Angioedema—Losartan—type 2 diabetes mellitus	0.000126	0.000898	CcSEcCtD
Esmolol—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000125	0.00089	CcSEcCtD
Esmolol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000125	0.000889	CcSEcCtD
Esmolol—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000125	0.000889	CcSEcCtD
Esmolol—Shock—Metformin—type 2 diabetes mellitus	0.000125	0.000888	CcSEcCtD
Esmolol—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000124	0.000886	CcSEcCtD
Esmolol—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000124	0.000885	CcSEcCtD
Esmolol—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000124	0.000884	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000124	0.000883	CcSEcCtD
Esmolol—Somnolence—Valsartan—type 2 diabetes mellitus	0.000124	0.000881	CcSEcCtD
Esmolol—Syncope—Losartan—type 2 diabetes mellitus	0.000124	0.000881	CcSEcCtD
Esmolol—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000123	0.00088	CcSEcCtD
Esmolol—Skin disorder—Metformin—type 2 diabetes mellitus	0.000123	0.000877	CcSEcCtD
Esmolol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000122	0.000873	CcSEcCtD
Esmolol—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000122	0.000873	CcSEcCtD
Esmolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000122	0.000869	CcSEcCtD
Esmolol—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000122	0.000869	CcSEcCtD
Esmolol—Nausea—Glimepiride—type 2 diabetes mellitus	0.000121	0.000866	CcSEcCtD
Esmolol—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000121	0.000864	CcSEcCtD
Esmolol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000121	0.000863	CcSEcCtD
Esmolol—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000121	0.000862	CcSEcCtD
Esmolol—Asthenia—Glyburide—type 2 diabetes mellitus	0.000121	0.000862	CcSEcCtD
Esmolol—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000121	0.000862	CcSEcCtD
Esmolol—Anorexia—Metformin—type 2 diabetes mellitus	0.000121	0.000861	CcSEcCtD
Esmolol—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00012	0.000857	CcSEcCtD
Esmolol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00012	0.000856	CcSEcCtD
Esmolol—Fatigue—Valsartan—type 2 diabetes mellitus	0.00012	0.000855	CcSEcCtD
Esmolol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00012	0.000853	CcSEcCtD
Esmolol—Oedema—Irbesartan—type 2 diabetes mellitus	0.000119	0.000852	CcSEcCtD
Esmolol—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000119	0.000852	CcSEcCtD
Esmolol—Pruritus—Glyburide—type 2 diabetes mellitus	0.000119	0.00085	CcSEcCtD
Esmolol—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000119	0.000848	CcSEcCtD
Esmolol—Constipation—Valsartan—type 2 diabetes mellitus	0.000119	0.000848	CcSEcCtD
Esmolol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000119	0.000846	CcSEcCtD
Esmolol—Fatigue—Orlistat—type 2 diabetes mellitus	0.000118	0.000845	CcSEcCtD
Esmolol—Hypotension—Metformin—type 2 diabetes mellitus	0.000118	0.000844	CcSEcCtD
Esmolol—Erythema—Ramipril—type 2 diabetes mellitus	0.000118	0.000842	CcSEcCtD
Esmolol—Shock—Irbesartan—type 2 diabetes mellitus	0.000118	0.000838	CcSEcCtD
Esmolol—Pain—Orlistat—type 2 diabetes mellitus	0.000117	0.000838	CcSEcCtD
Esmolol—Chest pain—Losartan—type 2 diabetes mellitus	0.000117	0.000836	CcSEcCtD
Esmolol—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000836	CcSEcCtD
Esmolol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000117	0.000836	CcSEcCtD
Esmolol—Anxiety—Losartan—type 2 diabetes mellitus	0.000117	0.000834	CcSEcCtD
Esmolol—Propafenone—CYP1A2—type 2 diabetes mellitus	0.000116	0.031	CrCbGaD
Esmolol—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000116	0.000828	CcSEcCtD
Esmolol—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000116	0.000825	CcSEcCtD
Esmolol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000115	0.000824	CcSEcCtD
Esmolol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000115	0.000824	CcSEcCtD
Esmolol—Dry mouth—Losartan—type 2 diabetes mellitus	0.000115	0.000818	CcSEcCtD
Esmolol—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000114	0.000812	CcSEcCtD
Esmolol—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000114	0.000811	CcSEcCtD
Esmolol—Confusional state—Losartan—type 2 diabetes mellitus	0.000113	0.000808	CcSEcCtD
Esmolol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000113	0.000807	CcSEcCtD
Esmolol—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000113	0.000805	CcSEcCtD
Esmolol—Somnolence—Metformin—type 2 diabetes mellitus	0.000113	0.000803	CcSEcCtD
Esmolol—Oedema—Losartan—type 2 diabetes mellitus	0.000112	0.000802	CcSEcCtD
Esmolol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000112	0.000796	CcSEcCtD
Esmolol—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000111	0.000795	CcSEcCtD
Esmolol—Shock—Losartan—type 2 diabetes mellitus	0.000111	0.000789	CcSEcCtD
Esmolol—Urticaria—Valsartan—type 2 diabetes mellitus	0.00011	0.000788	CcSEcCtD
Esmolol—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00011	0.000786	CcSEcCtD
Esmolol—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00011	0.000785	CcSEcCtD
Esmolol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000109	0.000781	CcSEcCtD
Esmolol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000109	0.000779	CcSEcCtD
Esmolol—Fatigue—Metformin—type 2 diabetes mellitus	0.000109	0.000778	CcSEcCtD
Esmolol—Urticaria—Orlistat—type 2 diabetes mellitus	0.000109	0.000778	CcSEcCtD
Esmolol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000109	0.000775	CcSEcCtD
Esmolol—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000109	0.000774	CcSEcCtD
Esmolol—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000109	0.000774	CcSEcCtD
Esmolol—Agitation—Ramipril—type 2 diabetes mellitus	0.000109	0.000774	CcSEcCtD
Esmolol—Constipation—Metformin—type 2 diabetes mellitus	0.000108	0.000772	CcSEcCtD
Esmolol—Angioedema—Ramipril—type 2 diabetes mellitus	0.000108	0.00077	CcSEcCtD
Esmolol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000107	0.000765	CcSEcCtD
Esmolol—Anorexia—Losartan—type 2 diabetes mellitus	0.000107	0.000764	CcSEcCtD
Esmolol—Vomiting—Glyburide—type 2 diabetes mellitus	0.000107	0.000764	CcSEcCtD
Esmolol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000107	0.000763	CcSEcCtD
Esmolol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000106	0.00076	CcSEcCtD
Esmolol—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000106	0.000757	CcSEcCtD
Esmolol—Syncope—Ramipril—type 2 diabetes mellitus	0.000106	0.000755	CcSEcCtD
Esmolol—Headache—Glyburide—type 2 diabetes mellitus	0.000106	0.000753	CcSEcCtD
Esmolol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000105	0.00075	CcSEcCtD
Esmolol—Hypotension—Losartan—type 2 diabetes mellitus	0.000105	0.000749	CcSEcCtD
Esmolol—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000104	0.000744	CcSEcCtD
Esmolol—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000104	0.000741	CcSEcCtD
Esmolol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000104	0.00074	CcSEcCtD
Esmolol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000103	0.000736	CcSEcCtD
Esmolol—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000103	0.000735	CcSEcCtD
Esmolol—Convulsion—Ramipril—type 2 diabetes mellitus	0.000102	0.00073	CcSEcCtD
Esmolol—Pain—Irbesartan—type 2 diabetes mellitus	0.000102	0.000729	CcSEcCtD
Esmolol—Constipation—Irbesartan—type 2 diabetes mellitus	0.000102	0.000729	CcSEcCtD
Esmolol—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000101	0.00072	CcSEcCtD
Esmolol—Urticaria—Metformin—type 2 diabetes mellitus	0.000101	0.000717	CcSEcCtD
Esmolol—Chest pain—Ramipril—type 2 diabetes mellitus	0.000101	0.000717	CcSEcCtD
Esmolol—Dyspnoea—Losartan—type 2 diabetes mellitus	0.0001	0.000715	CcSEcCtD
Esmolol—Anxiety—Ramipril—type 2 diabetes mellitus	0.0001	0.000715	CcSEcCtD
Esmolol—Nausea—Glyburide—type 2 diabetes mellitus	0.0001	0.000714	CcSEcCtD
Esmolol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.0001	0.000714	CcSEcCtD
Esmolol—Somnolence—Losartan—type 2 diabetes mellitus	9.99e-05	0.000713	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	9.99e-05	0.000712	CcSEcCtD
Esmolol—Asthenia—Valsartan—type 2 diabetes mellitus	9.97e-05	0.000711	CcSEcCtD
Esmolol—Dyspepsia—Losartan—type 2 diabetes mellitus	9.89e-05	0.000706	CcSEcCtD
Esmolol—Asthenia—Orlistat—type 2 diabetes mellitus	9.85e-05	0.000703	CcSEcCtD
Esmolol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.84e-05	0.000702	CcSEcCtD
Esmolol—Pruritus—Valsartan—type 2 diabetes mellitus	9.83e-05	0.000701	CcSEcCtD
Esmolol—Dry mouth—Ramipril—type 2 diabetes mellitus	9.83e-05	0.000701	CcSEcCtD
Esmolol—Decreased appetite—Losartan—type 2 diabetes mellitus	9.77e-05	0.000697	CcSEcCtD
Esmolol—Confusional state—Ramipril—type 2 diabetes mellitus	9.72e-05	0.000693	CcSEcCtD
Esmolol—Pruritus—Orlistat—type 2 diabetes mellitus	9.72e-05	0.000693	CcSEcCtD
Esmolol—Fatigue—Losartan—type 2 diabetes mellitus	9.69e-05	0.000691	CcSEcCtD
Esmolol—Oedema—Ramipril—type 2 diabetes mellitus	9.64e-05	0.000688	CcSEcCtD
Esmolol—Vomiting—Gliclazide—type 2 diabetes mellitus	9.62e-05	0.000686	CcSEcCtD
Esmolol—Constipation—Losartan—type 2 diabetes mellitus	9.61e-05	0.000686	CcSEcCtD
Esmolol—Pain—Losartan—type 2 diabetes mellitus	9.61e-05	0.000686	CcSEcCtD
Esmolol—Urticaria—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.000677	CcSEcCtD
Esmolol—Shock—Ramipril—type 2 diabetes mellitus	9.48e-05	0.000676	CcSEcCtD
Esmolol—Headache—Gliclazide—type 2 diabetes mellitus	9.48e-05	0.000676	CcSEcCtD
Esmolol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.45e-05	0.000674	CcSEcCtD
Esmolol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.44e-05	0.000674	CcSEcCtD
Esmolol—Skin disorder—Ramipril—type 2 diabetes mellitus	9.36e-05	0.000668	CcSEcCtD
Esmolol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.32e-05	0.000665	CcSEcCtD
Esmolol—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.26e-05	0.000661	CcSEcCtD
Esmolol—Dizziness—Valsartan—type 2 diabetes mellitus	9.19e-05	0.000656	CcSEcCtD
Esmolol—Anorexia—Ramipril—type 2 diabetes mellitus	9.19e-05	0.000655	CcSEcCtD
Esmolol—Dizziness—Orlistat—type 2 diabetes mellitus	9.08e-05	0.000648	CcSEcCtD
Esmolol—Asthenia—Metformin—type 2 diabetes mellitus	9.08e-05	0.000648	CcSEcCtD
Esmolol—Hypotension—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000642	CcSEcCtD
Esmolol—Nausea—Gliclazide—type 2 diabetes mellitus	8.99e-05	0.000641	CcSEcCtD
Esmolol—Pruritus—Metformin—type 2 diabetes mellitus	8.95e-05	0.000639	CcSEcCtD
Esmolol—Urticaria—Losartan—type 2 diabetes mellitus	8.93e-05	0.000637	CcSEcCtD
Esmolol—Body temperature increased—Losartan—type 2 diabetes mellitus	8.89e-05	0.000634	CcSEcCtD
Esmolol—Vomiting—Valsartan—type 2 diabetes mellitus	8.84e-05	0.00063	CcSEcCtD
Esmolol—Vomiting—Orlistat—type 2 diabetes mellitus	8.73e-05	0.000623	CcSEcCtD
Esmolol—Headache—Valsartan—type 2 diabetes mellitus	8.71e-05	0.000621	CcSEcCtD
Esmolol—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000617	CcSEcCtD
Esmolol—Headache—Orlistat—type 2 diabetes mellitus	8.6e-05	0.000614	CcSEcCtD
Esmolol—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000613	CcSEcCtD
Esmolol—Asthenia—Irbesartan—type 2 diabetes mellitus	8.57e-05	0.000611	CcSEcCtD
Esmolol—Somnolence—Ramipril—type 2 diabetes mellitus	8.57e-05	0.000611	CcSEcCtD
Esmolol—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.48e-05	0.000605	CcSEcCtD
Esmolol—Pruritus—Irbesartan—type 2 diabetes mellitus	8.45e-05	0.000603	CcSEcCtD
Esmolol—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.38e-05	0.000598	CcSEcCtD
Esmolol—Dizziness—Metformin—type 2 diabetes mellitus	8.37e-05	0.000597	CcSEcCtD
Esmolol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.32e-05	0.000594	CcSEcCtD
Esmolol—Fatigue—Ramipril—type 2 diabetes mellitus	8.31e-05	0.000593	CcSEcCtD
Esmolol—Nausea—Valsartan—type 2 diabetes mellitus	8.26e-05	0.000589	CcSEcCtD
Esmolol—Constipation—Ramipril—type 2 diabetes mellitus	8.24e-05	0.000588	CcSEcCtD
Esmolol—Nausea—Orlistat—type 2 diabetes mellitus	8.16e-05	0.000582	CcSEcCtD
Esmolol—Asthenia—Losartan—type 2 diabetes mellitus	8.07e-05	0.000575	CcSEcCtD
Esmolol—Vomiting—Metformin—type 2 diabetes mellitus	8.05e-05	0.000574	CcSEcCtD
Esmolol—Propranolol—CYP1A2—type 2 diabetes mellitus	7.97e-05	0.0212	CrCbGaD
Esmolol—Pruritus—Losartan—type 2 diabetes mellitus	7.95e-05	0.000567	CcSEcCtD
Esmolol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.94e-05	0.000567	CcSEcCtD
Esmolol—Headache—Metformin—type 2 diabetes mellitus	7.93e-05	0.000566	CcSEcCtD
Esmolol—Dizziness—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.000563	CcSEcCtD
Esmolol—Propafenone—CYP3A4—type 2 diabetes mellitus	7.71e-05	0.0205	CrCbGaD
Esmolol—Urticaria—Ramipril—type 2 diabetes mellitus	7.66e-05	0.000546	CcSEcCtD
Esmolol—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.62e-05	0.000544	CcSEcCtD
Esmolol—Vomiting—Irbesartan—type 2 diabetes mellitus	7.59e-05	0.000542	CcSEcCtD
Esmolol—Nausea—Metformin—type 2 diabetes mellitus	7.52e-05	0.000536	CcSEcCtD
Esmolol—Headache—Irbesartan—type 2 diabetes mellitus	7.48e-05	0.000534	CcSEcCtD
Esmolol—Dizziness—Losartan—type 2 diabetes mellitus	7.43e-05	0.00053	CcSEcCtD
Esmolol—Vomiting—Losartan—type 2 diabetes mellitus	7.15e-05	0.00051	CcSEcCtD
Esmolol—Nausea—Irbesartan—type 2 diabetes mellitus	7.09e-05	0.000506	CcSEcCtD
Esmolol—Headache—Losartan—type 2 diabetes mellitus	7.04e-05	0.000502	CcSEcCtD
Esmolol—Asthenia—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000493	CcSEcCtD
Esmolol—Pruritus—Ramipril—type 2 diabetes mellitus	6.82e-05	0.000486	CcSEcCtD
Esmolol—Nausea—Losartan—type 2 diabetes mellitus	6.68e-05	0.000476	CcSEcCtD
Esmolol—Dizziness—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000455	CcSEcCtD
Esmolol—Vomiting—Ramipril—type 2 diabetes mellitus	6.13e-05	0.000437	CcSEcCtD
Esmolol—Headache—Ramipril—type 2 diabetes mellitus	6.04e-05	0.000431	CcSEcCtD
Esmolol—Ibuprofen—PTGS2—type 2 diabetes mellitus	5.87e-05	0.0156	CrCbGaD
Esmolol—Nausea—Ramipril—type 2 diabetes mellitus	5.73e-05	0.000408	CcSEcCtD
Esmolol—Propranolol—CYP3A4—type 2 diabetes mellitus	5.28e-05	0.014	CrCbGaD
Esmolol—Ibuprofen—ALB—type 2 diabetes mellitus	5.23e-05	0.0139	CrCbGaD
Esmolol—ADRB1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	3.26e-05	0.000798	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—C3—type 2 diabetes mellitus	3.22e-05	0.000787	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	3.21e-05	0.000786	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	3.19e-05	0.000781	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GIPR—type 2 diabetes mellitus	3.16e-05	0.000773	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GRK5—type 2 diabetes mellitus	3.16e-05	0.000773	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	3.13e-05	0.000765	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—AGT—type 2 diabetes mellitus	3.12e-05	0.000765	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GRK5—type 2 diabetes mellitus	3.09e-05	0.000756	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GIPR—type 2 diabetes mellitus	3.09e-05	0.000756	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	3.06e-05	0.000748	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—AGT—type 2 diabetes mellitus	3.06e-05	0.000748	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	3.05e-05	0.000747	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	3.03e-05	0.000742	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	2.99e-05	0.000731	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	2.98e-05	0.000729	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	2.97e-05	0.000726	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	2.96e-05	0.000725	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	2.95e-05	0.000722	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	2.92e-05	0.000713	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	2.9e-05	0.000709	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MC4R—type 2 diabetes mellitus	2.89e-05	0.000707	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	2.89e-05	0.000707	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	2.89e-05	0.000706	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	2.88e-05	0.000704	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	2.84e-05	0.000695	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	2.84e-05	0.000694	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MC4R—type 2 diabetes mellitus	2.83e-05	0.000692	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	2.83e-05	0.000691	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	2.81e-05	0.000688	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GIP—type 2 diabetes mellitus	2.78e-05	0.000681	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	2.78e-05	0.00068	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	2.78e-05	0.000679	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	2.76e-05	0.000674	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GIP—type 2 diabetes mellitus	2.72e-05	0.000666	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	2.7e-05	0.000659	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	2.68e-05	0.000656	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LEPR—type 2 diabetes mellitus	2.64e-05	0.000647	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	2.63e-05	0.000644	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	2.62e-05	0.000642	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	2.62e-05	0.000641	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	2.61e-05	0.000639	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	2.59e-05	0.000633	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LEPR—type 2 diabetes mellitus	2.59e-05	0.000633	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	2.58e-05	0.000631	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	2.57e-05	0.00063	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	2.57e-05	0.00063	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	2.57e-05	0.000628	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	2.56e-05	0.000625	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	2.53e-05	0.000619	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	2.53e-05	0.000618	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	2.52e-05	0.000617	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	2.52e-05	0.000616	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	2.47e-05	0.000604	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TLE4—type 2 diabetes mellitus	2.46e-05	0.000601	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TLE4—type 2 diabetes mellitus	2.4e-05	0.000588	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GCG—type 2 diabetes mellitus	2.39e-05	0.000584	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	2.37e-05	0.000579	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	2.35e-05	0.000575	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GCG—type 2 diabetes mellitus	2.34e-05	0.000572	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	2.31e-05	0.000566	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	2.3e-05	0.000562	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	2.28e-05	0.000559	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	2.27e-05	0.000555	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	2.24e-05	0.000547	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	2.23e-05	0.000547	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	2.22e-05	0.000543	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	2.19e-05	0.000535	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	2.13e-05	0.000521	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	2.11e-05	0.000516	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	2.09e-05	0.000511	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	2.09e-05	0.000511	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	2.08e-05	0.000509	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	2.06e-05	0.000504	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	2.06e-05	0.000504	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	2.04e-05	0.0005	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	2.04e-05	0.0005	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RBP4—type 2 diabetes mellitus	2.04e-05	0.000498	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	2.04e-05	0.000498	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AVP—type 2 diabetes mellitus	2.03e-05	0.000497	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	2.03e-05	0.000497	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	2.02e-05	0.000494	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	2.01e-05	0.000493	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	2e-05	0.00049	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.99e-05	0.000487	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.99e-05	0.000487	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AVP—type 2 diabetes mellitus	1.99e-05	0.000486	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	1.99e-05	0.000486	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	1.98e-05	0.000484	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.96e-05	0.000479	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.93e-05	0.000473	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	1.9e-05	0.000465	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.89e-05	0.000462	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	1.86e-05	0.000455	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.86e-05	0.000455	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.84e-05	0.000449	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.82e-05	0.000445	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.81e-05	0.000444	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.8e-05	0.000441	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.8e-05	0.000439	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.79e-05	0.000439	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.78e-05	0.000434	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.77e-05	0.000432	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.76e-05	0.000432	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.76e-05	0.000431	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.76e-05	0.00043	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	1.75e-05	0.000429	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.75e-05	0.000428	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.73e-05	0.000423	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.73e-05	0.000423	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.72e-05	0.000421	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.72e-05	0.000421	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.71e-05	0.000419	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.69e-05	0.000413	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—C3—type 2 diabetes mellitus	1.69e-05	0.000413	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.68e-05	0.00041	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	1.65e-05	0.000404	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.64e-05	0.000401	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.63e-05	0.000399	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.63e-05	0.000398	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.63e-05	0.000398	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.6e-05	0.000392	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.6e-05	0.000391	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.59e-05	0.00039	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.59e-05	0.00039	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.58e-05	0.000387	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.58e-05	0.000386	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.58e-05	0.000386	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.57e-05	0.000384	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.55e-05	0.000379	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.55e-05	0.000379	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.54e-05	0.000377	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.54e-05	0.000377	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.54e-05	0.000377	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.54e-05	0.000377	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.52e-05	0.000373	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.52e-05	0.000371	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.51e-05	0.000369	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.51e-05	0.000369	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.49e-05	0.000365	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.48e-05	0.000363	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.45e-05	0.000355	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.44e-05	0.000351	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.43e-05	0.00035	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.41e-05	0.000345	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.41e-05	0.000345	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.4e-05	0.000344	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.4e-05	0.000342	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.39e-05	0.00034	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.38e-05	0.000339	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.38e-05	0.000338	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	1.38e-05	0.000338	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.36e-05	0.000332	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.35e-05	0.000331	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.32e-05	0.000323	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.3e-05	0.000317	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.3e-05	0.000317	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.29e-05	0.000316	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.27e-05	0.000311	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.27e-05	0.00031	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.23e-05	0.0003	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.22e-05	0.000298	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.2e-05	0.000294	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.2e-05	0.000294	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.2e-05	0.000294	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.19e-05	0.000292	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.19e-05	0.000291	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.19e-05	0.000291	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.18e-05	0.000288	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.17e-05	0.000287	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.17e-05	0.000287	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.17e-05	0.000286	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.16e-05	0.000285	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.16e-05	0.000284	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.16e-05	0.000283	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.15e-05	0.000282	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.14e-05	0.000279	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.13e-05	0.000278	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.13e-05	0.000276	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.12e-05	0.000273	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.11e-05	0.000271	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.08e-05	0.000265	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.08e-05	0.000265	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.06e-05	0.000259	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.04e-05	0.000254	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.02e-05	0.00025	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.02e-05	0.000249	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.98e-06	0.000244	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	9.97e-06	0.000244	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	9.75e-06	0.000239	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.51e-06	0.000233	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.49e-06	0.000232	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	9.47e-06	0.000232	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.31e-06	0.000228	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.3e-06	0.000228	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	9.28e-06	0.000227	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	9.28e-06	0.000227	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.28e-06	0.000227	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	9.27e-06	0.000227	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.18e-06	0.000224	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.11e-06	0.000223	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	9.08e-06	0.000222	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	9.08e-06	0.000222	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.98e-06	0.00022	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.75e-06	0.000214	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.56e-06	0.000209	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.28e-06	0.000203	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.1e-06	0.000198	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	7.93e-06	0.000194	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.8e-06	0.000191	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	7.76e-06	0.00019	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.67e-06	0.000188	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.66e-06	0.000188	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.63e-06	0.000187	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.63e-06	0.000187	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.5e-06	0.000184	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.5e-06	0.000183	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.47e-06	0.000183	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.28e-06	0.000178	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.13e-06	0.000174	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.95e-06	0.00017	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.95e-06	0.00017	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.8e-06	0.000166	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.8e-06	0.000166	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.55e-06	0.00016	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	6.4e-06	0.000157	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.96e-06	0.000146	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.9e-06	0.000144	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.87e-06	0.000143	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.83e-06	0.000143	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.78e-06	0.000141	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.74e-06	0.00014	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.58e-06	0.000136	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.52e-06	0.000135	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.46e-06	0.000134	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.41e-06	0.000132	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.4e-06	0.000132	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.29e-06	0.00013	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.14e-06	0.000126	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	5.03e-06	0.000123	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.01e-06	0.000123	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.9e-06	0.00012	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.6e-06	0.000112	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.51e-06	0.00011	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.5e-06	0.00011	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.41e-06	0.000108	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.46e-06	8.48e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.39e-06	8.29e-05	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.2e-06	7.82e-05	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.13e-06	7.65e-05	CbGpPWpGaD
